Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001036050-00-000357
Filing Date
2000-03-15
Accepted
2000-03-15 00:00:00
Documents
7
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K405 226551
2 PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT EX-10.24 151238
3 COLLABORATION AND LICENSE AGREEMENT EX-10.25 348048
4 STOCK PURCHASE AGREEMENT EX-10.26 67470
5 STATEMENT OF COMPUTATION OF LOSS PER SHARE EX-11 1630
6 CONSENT OF KPMG LLP EX-23 993
7 FINANCIAL DATA SCHEDULE EX-27 2047
  Complete submission text file 0001036050-00-000357.txt   800051
Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21699 | Film No.: 570127
SIC: 2834 Pharmaceutical Preparations